We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




MRI Superior to ECG for Diagnosing Heart Failure

By HospiMedica International staff writers
Posted on 06 May 2022

Until now, the best way of diagnosing heart failure has been an invasive assessment, but it carries risks for patients. More...

Non-invasive echocardiogram, which is based on ultrasound, are usually used instead, but they are wrong in up to 50% of cases. Now, a new study has shown how magnetic resonance imaging (MRI) is superior to Echocardiography for diagnosing heart failure, as well as being a powerful tool to predict patient outcomes, including death.

Using MRI scans to detect heart failure could revolutionize how the condition is diagnosed, thanks to new research from the research from the University of East Anglia (UEA, Norfolk, UK) and the University of Sheffield (Sheffield, UK). The research team studied 835 patients who received an invasive assessment and a heart MRI on the same day from the ASPIRE registry - a database of patients assessed at the Sheffield Pulmonary Vascular Disease Unit.

“We showed that heart MRI is superior to Echocardiography in predicting pressure inside the heart. Almost 71% of patients who had wrongly measured pressures by Echocardiography had correct pressures by heart MRI,” said lead researcher Dr. Pankaj Garg, from UEA’s Norwich Medical School. “These findings will reduce the need for invasive assessment. This is not only cost-effective but also reduces risks to patients, as a heart MRI scan is a completely non-invasive test. We also showed that the results from heart MRIs were powerful tools to predict whether a patient would live or die.”

Related Links:
University of East Anglia 
University of Sheffield 


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.